NO873860D0 - IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION. - Google Patents

IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION.

Info

Publication number
NO873860D0
NO873860D0 NO873860A NO873860A NO873860D0 NO 873860 D0 NO873860 D0 NO 873860D0 NO 873860 A NO873860 A NO 873860A NO 873860 A NO873860 A NO 873860A NO 873860 D0 NO873860 D0 NO 873860D0
Authority
NO
Norway
Prior art keywords
ifosphamide
lyophilizate
procedure
preparation
ifosfamide
Prior art date
Application number
NO873860A
Other languages
Norwegian (no)
Other versions
NO873860L (en
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of NO873860D0 publication Critical patent/NO873860D0/en
Publication of NO873860L publication Critical patent/NO873860L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Amplifiers (AREA)

Abstract

1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
NO873860A 1986-10-31 1987-09-15 IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION. NO873860L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (2)

Publication Number Publication Date
NO873860D0 true NO873860D0 (en) 1987-09-15
NO873860L NO873860L (en) 1988-05-02

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873860A NO873860L (en) 1986-10-31 1987-09-15 IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION.

Country Status (25)

Country Link
EP (1) EP0265812B1 (en)
JP (1) JPS63159319A (en)
KR (1) KR900003491B1 (en)
AT (1) ATE55250T1 (en)
AU (1) AU598602B2 (en)
CA (1) CA1314231C (en)
DD (1) DD262582A5 (en)
DE (1) DE3764235D1 (en)
DK (1) DK169308B1 (en)
EG (1) EG18333A (en)
ES (1) ES2017982B3 (en)
FI (1) FI87140C (en)
GE (1) GEP19971025B (en)
GR (1) GR3000708T3 (en)
HU (1) HU197987B (en)
IL (1) IL84312A (en)
IN (1) IN168119B (en)
LV (1) LV10051B (en)
MX (1) MX8958A (en)
NO (1) NO873860L (en)
PT (1) PT86032B (en)
RU (1) RU1836079C (en)
UA (1) UA11075A (en)
YU (1) YU197387A (en)
ZA (1) ZA878183B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2040394T3 (en) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft PROCEDURE FOR PREPARING A LYOPHILIZED MATERIAL OF IFOSFAMIDE AND MESNA.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (en) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamide lyophilizate preparations
KR20010034552A (en) * 1998-03-03 2001-04-25 요시히코 시오노 Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate
NZ538584A (en) * 2002-09-05 2007-05-31 Bharat Serums & Vaccines Ltd Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin
EP1569663B1 (en) * 2002-12-02 2010-04-28 Bharat Serums & Vaccines Ltd. Ifosfamide compositions for parenteral administration and a process for their preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
EP2412359A1 (en) * 2006-09-29 2012-02-01 Infa S.A. Packaging system for pharmaceutical compositions and kit for intravenous administration
CN105900385B (en) * 2014-12-04 2019-08-27 华为技术有限公司 Load distribution in data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (en) * 1977-05-09 1978-11-16 Walton J Smith Anhydrous compsn. prodn. by freeze drying hydrated, hydrolysable prod. - esp. aspirin or aspirin salt solns.
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
GR3000708T3 (en) 1991-10-10
UA11075A (en) 1996-12-25
LV10051B (en) 1995-06-20
JPH0543684B2 (en) 1993-07-02
AU8052987A (en) 1988-05-05
ES2017982B3 (en) 1991-03-16
IL84312A (en) 1991-11-21
IL84312A0 (en) 1988-03-31
DK169308B1 (en) 1994-10-10
FI874727A (en) 1988-05-01
LV10051A (en) 1994-05-10
DK569687D0 (en) 1987-10-30
YU197387A (en) 1988-12-31
DK569687A (en) 1988-05-01
ZA878183B (en) 1988-05-02
EP0265812A1 (en) 1988-05-04
HU197987B (en) 1989-07-28
DE3764235D1 (en) 1990-09-13
DD262582A5 (en) 1988-12-07
GEP19971025B (en) 1997-04-06
ATE55250T1 (en) 1990-08-15
AU598602B2 (en) 1990-06-28
KR900003491B1 (en) 1990-05-21
RU1836079C (en) 1993-08-23
PT86032B (en) 1990-08-31
FI87140B (en) 1992-08-31
PT86032A (en) 1987-11-01
FI874727A0 (en) 1987-10-27
NO873860L (en) 1988-05-02
HUT44932A (en) 1988-05-30
KR880004814A (en) 1988-06-27
EP0265812B1 (en) 1990-08-08
CA1314231C (en) 1993-03-09
EG18333A (en) 1993-12-30
JPS63159319A (en) 1988-07-02
MX8958A (en) 1993-12-01
FI87140C (en) 1992-12-10
IN168119B (en) 1991-02-09

Similar Documents

Publication Publication Date Title
NO900528D0 (en) ANTHELMINTICS, PROCEDURE FOR PREPARING THEREOF, AND PREPARATION WITH A CONTENT THEREOF.
PT90030A (en) PROCESS FOR THE PREPARATION OF IFOSPHAMIDE AND MESNA LYOPHYLISATE
DK11992D0 (en) EPIPODOPHYLLOTOXINGLYCOSIDE-4'-PHOSPHATE DERIVATIVES, THEIR PREPARATION AND USE
NO172344C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED FLAVONOID COMPOUNDS AND SALTS
SE8603582D0 (en) COMPOSITION CONTAINING L-DOPA
NO873860D0 (en) IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION.
NO870512D0 (en) 1,4-BENZOCSAZINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO874892D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3- (OMEGA- (3,5-DI-T-BUTYL-4-HYDROXYPHENYL) -ALKANOYL) PYROLES AND THEIR DEOXY ANALOGS.
DK103987A (en) SUBSTITUTED 1,3,4,9-TETRAHYDROPYRANOE3,4-BAAINDOL-L-ACETIC ACIDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK707988A (en) PROCEDURE TO HAVE VIRUS
DK422488D0 (en) ARYL PYROLES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES, ACARICIDES AND NEMATODICIDES
NO871481L (en) SUBSTITUTED THIACYCLOALKENO (3,2-B) PYRIDINES AND PROCEDURES FOR THEIR PREPARATION.
NO883520D0 (en) PROCEDURE FOR THE PREPARATION OF AN INJECTION PREPARATION.
DK497888D0 (en) N- (SUBSTITUTED ALKYLIDE) -1,2,3,4-TETRAHYDRO-9-A CRIDINAMINES, THEIR PREPARATION AND USE
NO892087D0 (en) PROCEDURE FOR THE PREPARATION OF NEW AVERMECTINES WITH SIMPLIFIED FURANRING AND AN 8ALFA HYDROXY GROUP.
NO872885L (en) 1,3,5-TRITIAN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
NO880639D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXIMETERS OF 2,6-DIOKSABICYCLO (3, 3, 0) OCTANONS.
NO164539C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-NAFTHYL-2,4-DIMETHYL-3H-1,2,4-TRIAZOL-3-THION.
NO912745L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2,5,6-TETRAHYDROPYRIDE COMPOUNDS.
ATE75613T1 (en) 17-BENZYLSPAREINE DERIVATIVES CONTAINING POSITIVE INOTROPIC PHARMACEUTICAL PREPARATIONS.